FY2025 EPS Estimates for JSPR Boosted by Cantor Fitzgerald
Jasper Therapeutics, Inc. (NASDAQ:JSPR – Free Report) – Cantor Fitzgerald raised their FY2025 earnings per share (EPS) estimates for Jasper Therapeutics in a research note issued on Tuesday, March 4th. Cantor Fitzgerald analyst P. Stavropoulos now expects that the company will earn ($4.17) per share for the year, up from their previous estimate of ($4.24). […]
Jasper Therapeutics, Inc. (NASDAQ:JSPR – Free Report) – Cantor Fitzgerald raised their FY2025 earnings per share (EPS) estimates for Jasper Therapeutics in a research note issued on Tuesday, March 4th. Cantor Fitzgerald analyst P. Stavropoulos now expects that the company will earn ($4.17) per share for the year, up from their previous estimate of ($4.24). […]
